Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adiga Life Sciences
Hamilton, Ontario, Canadasynapseconsortium.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Adiga Life Sciences has demonstrated in published clinical studies that its lead asset, Cat-PAD, a peptide-based immunotherapy for cat allergy, can reduce immune response and symptoms of allergic rhinitis. The therapy uses synthetic peptides derived from the major cat allergen Fel d 1 to induce immune tolerance. A recent pilot study showed significant improvement in nasal symptom scores and immune cell changes after four injections over three months. Previous studies indicated durable symptom reduction for up to two years with this regimen.
- Therapeutic areas
- Immunology
- Modalities
- Peptide immunotherapySynthetic peptide immuno-regulatory epitopesBiologic (immunomodulatory assets)
- Industry
- Biotech
02
Partnerships
PROOF Centre of Excellence for biomarker discovery/validationAllerGen NCE Inc. network for clinical research collaboration
Beyond the preview
Go deeper on Adiga Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adiga Life Sciences.